Bausch Health (BHC) reported Q4 earnings Wednesday of $0.25 per diluted share, compared with a per-share loss of $0.11 a year earlier.
Two analysts polled by FactSet expected $0.23.
Revenue for the quarter ended Dec. 31 was $2.56 billion, up from $2.41 billion a year earlier.
Analysts surveyed by FactSet expected $2.52 billion.
The company said it expects 2025 revenue between $9.90 billion and $10.15 billion.
Analysts polled by FactSet expect $9.91 billion.
Shares of Bausch Health were up 7.5% in after-hours trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.